ONCY
Oncolytics Biotech Inc.
NASDAQ · Healthcare · Biotechnology · CA
$0.84
−1.55%Jun 2, 2026, 00:00 UTC
Oncolytics Biotech Inc. appointed Stephen Glover as a director, with an option to purchase 96,000 shares vesting over three years.
Jun 2, 2026, 00:00 UTC
Oncolytics Biotech Inc. appointed John McAdory as Chief Operating Officer, effective June 1, 2026.